Uzun Serife, Wang Zixi, McKnight Tory A, Ehrlich Paul, Thanik Erin, Nowak-Wegrzyn Anna, Yang Nan, Li Xiu-Min
New York Institute of Technology College of Osteopathic, Old Westbury, NY, 11545, USA.
Department of Allergy, Peking Union Medical College Hospital, Beijing, 100730, China.
Allergy Asthma Clin Immunol. 2021 Jul 9;17(1):68. doi: 10.1186/s13223-021-00555-0.
We recently showed that multicomponent traditional Chinese medicine (TCM) therapy had steroid-sparing effects in moderate-to-severe eczema. We sought to evaluate TCM effects in severe eczema in a 7-year-old male with refractory disease and corticosteroid withdrawal syndrome.
Prior to referral, the patient had been treated since infancy with increasingly intensive standard of care, including high-dose topical and systemic corticosteroid and antibiotic therapy and was unable to tolerate further steroid treatment. The patient was administered a combination of oral and topical TCM for 17 months following discontinuation of his steroid regimen. His overall medical condition was assessed by SCORAD criteria and laboratory evaluations of serum IgE, absolute eosinophil count, and liver and kidney function tests.
The patient showed rapid improvement of clinical measures of disease after starting TCM therapy, with marked improvement of sleep quality within the first week, complete resolution of itching, oozing, and erythema at 2 weeks, and a 79% and 99% decrease in his SCORAD values after one month and 3-6 months of TCM, respectively. Serum total IgE decreased by 75% (from 19,000 to 4630 (kIU/L), and absolute eosinophil counts decreased by 60% (from 1000 to 427 cells/μL) after 12 months of treatment. The patient did not require oral or topical steroids during the 17-month trial of TCM. TCM was tapered without complications. His dermatologic manifestations continued to be well-controlled 3 months after discontinuation.
This case study suggests TCM should be further evaluated in controlled clinical studies of patients with severe, refractory eczema and steroid withdrawal syndrome.
我们最近发现,多成分中药疗法对中重度湿疹具有激素节省效应。我们试图评估中药对一名患有难治性疾病和皮质类固醇戒断综合征的7岁男性重度湿疹的疗效。
在转诊之前,该患者自婴儿期起就接受了越来越强化的标准治疗,包括高剂量局部和全身皮质类固醇及抗生素治疗,且无法耐受进一步的类固醇治疗。在停止类固醇治疗方案后,该患者接受了17个月的口服和局部中药联合治疗。通过SCORAD标准以及血清IgE、绝对嗜酸性粒细胞计数和肝肾功能测试的实验室评估来评估他的整体健康状况。
该患者在开始中药治疗后,疾病的临床指标迅速改善,第一周内睡眠质量显著改善,2周时瘙痒、渗出和红斑完全消退,中药治疗1个月和3 - 6个月后,其SCORAD值分别下降了79%和99%。治疗12个月后,血清总IgE下降了75%(从19,000降至4630 (kIU/L)),绝对嗜酸性粒细胞计数下降了60%(从1000降至427个细胞/μL)。在17个月的中药治疗试验期间,该患者无需口服或局部使用类固醇。逐渐减少中药用量未出现并发症。停药3个月后,他的皮肤表现仍得到良好控制。
本病例研究表明,对于重度、难治性湿疹和类固醇戒断综合征患者,应在对照临床研究中进一步评估中药。